Sitagliptin And Metformin Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 70771-1886

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 70771-1886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (586136d7 1c08 4507 A8fc 946d5cbefebb 01)

Label (586136d7 1c08 4507 A8fc 946d5cbefebb 01)
Sitagliptin and Metformin Hydrochloride Extended-Release Tablets, 50 mg/500 mg, are oral medications recommended to be taken once daily with a meal, preferably in the evening. Each film-coated tablet contains Sitagliptin and Metformin Hydrochloride, USP 500 mg. The package contains 60 tablets to be used within 30 days of opening. It is advised to store the tablets at a temperature range of 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 85°F). It is recommended to keep the tablets in the original container tightly closed to protect them from moisture and out of reach of children. For more information, refer to the Prescribing Information or contact the manufacturer.*
FDA Label Image

Label (586136d7 1c08 4507 A8fc 946d5cbefebb 02)

Label (586136d7 1c08 4507 A8fc 946d5cbefebb 02)
This text provides information regarding Sitagliptin and Metformin Hydrochloride Extended-Release Tablets. The tablets contain 50mg of Sitagliptin and 1,000mg of Metformin Hydrochloride, with a recommended dosage of two tablets taken once daily with a meal, preferably in the evening. It is advised to use the tablets within 30 days of opening and store them in a cool, dry place at 20°C to 25°C. The package is child-resistant and should be kept tightly closed to protect it from moisture. It also emphasizes keeping all drugs out of the reach of children. A Medication Guide is available at the provided website or phone number.*
FDA Label Image

Label (586136d7 1c08 4507 A8fc 946d5cbefebb 03)

Label (586136d7 1c08 4507 A8fc 946d5cbefebb 03)
This is a description of Sitagliptin and Metformin Hydrochloride Extended-Release Tablets, used for oral administration at a dosage of 100 mg/1,000 mg. The tablets should be taken once daily with a meal, preferably in the evening, following the provided Prescribing information. It is recommended to use the tablets within 30 days of opening. Each tablet contains Sitagliptin and Metformin Hydrochloride. The package is child-resistant, and the tablets should be stored in a dry place at 20° to 25°C (68°F to 77°F). Remember to keep the tablets out of reach of children and discard after the expiration date. The Medication Guide can be accessed online or by calling a provided number. The manufacturer is Zydus Lifesciences Ltd. in Ahmedabad, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.